Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

The Prognostic Significance of Tumor-Infiltrating Lymphocytes, PD-L1, BRCA Mutation Status and Tumor Mutational Burden in Early-Stage High-Grade Serous Ovarian Carcinoma-A Study by the Spanish Group for Ovarian Cancer Research (GEICO)

  • Pizarro, David
  • Romero, Ignacio
  • Pérez-Mies, Belén
  • Redondo Sánchez, Andrés|||0000-0002-7257-5642
  • Caniego-Casas, Tamara
  • Carretero-Barrio, Irene|||0000-0003-1986-2965
  • Cristóbal, Eva
  • Gutiérrez-Pecharromán, Ana
  • Santaballa, Ana|||0000-0001-7763-320X
  • D'Angelo, Emanuela|||0000-0002-6173-1806
  • Hardisson, David|||0000-0002-2183-3699
  • Vieites, Begoña
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • Estévez-García, Purificación
  • Guerra, Eva|||0000-0003-1910-4451
  • Prat, Jaime|||0000-0002-9787-3304
  • Poveda, Andrés
  • López Guerrero, José Antonio|||0000-0002-7369-8388
  • Palacios, José|||0000-0002-6730-5066
Early stages are under-represented in studies on the molecular and immune features of high-grade serous ovarian carcinoma (HGSOC), and specific studies focused on early-stage HGSOC are required for a better prognostic stratification and to personalize chemotherapy. The aim of this study was to determine the prognostic significance of CD8+ and CD4+ tumor-infiltrating lymphocytes (TILs), tumoral cell PD-L1 expression, BRCA mutational status and tumor mutation burden (TMB) in early-stage HGSOC. A retrospective study was performed on stage I and II HGSOC from the Molecular Reclassification of Early Stages of Ovarian Cancer (RECLAMO) cohort from the Spanish Group of Ovarian Cancer Research (GEICO). Centralized histological typing was performed based on morphological and immunohistochemical features. Intraepithelial (i) and stromal (s) CD8+ and CD4+ T cells and PD-L1 were evaluated on tissue microarrays by immunohistochemistry. BRCA1 and BRCA2 mutation status and TMB were analyzed in tumor DNA using next-generation sequencing. The study included 124 tumors. High iCD8+ (.
Dipòsit Digital de Documents de la UAB
Publicación Artículo de revisión (ReviewArticle)

Clinical Features of Children With MOG-IgG Who Fulfill Criteria of Multiple Sclerosis and Overlapping Disorders

  • Fonseca, Elianet Gisell|||0000-0002-3613-3185
  • Olive Cirera, Gemma
  • Chen, Li Wen|||0000-0002-4013-8333
  • Paredes-Carmona, Fernando
  • Vázquez-López, Mara|||0000-0002-1599-8841
  • Felipe-Rucián, Ana|||0000-0002-5267-1370
  • Romeu, Gemma
  • Martínez Hernández, Eugenia
  • Blanco Morgado, Yolanda|||0000-0002-1834-0498
  • Sepulveda, Maria
  • Saiz, Albert|||0000-0002-5793-8791
  • Dalmau, Josep|||0000-0001-5856-2813
  • Armangue, Thais|||0000-0001-6192-6171
  • Nuñez Enamorado, Noem
  • Boyero Duran, Sabas
  • Mendibe-Bilbao, María del Mar
  • Visa-Reñé, Nuria
ObjectivesThe aim of this study was to report the clinical features, disease-modifying treatment (DMT) response, and outcomes of children with MOG-IgG who fulfill the 2017 McDonald criteria for multiple sclerosis (MS).MethodsThis prospective observational study included children (<18 years) with a suspected acquired demyelinating syndrome (ADS) whose serum or CSF was positive for MOG-IgG, who met the indicated MS criteria, and who had ≥1 year of clinical follow-up. MOG-IgG was tested using live cell-based assays.ResultsOf 554 children with confirmed ADS (196 with MOG-IgG), 8 (median age 11 years, interquartile range 9-14) harbored MOG-IgG and fulfilled MS criteria: 2 had typical MS and 6 had overlapping MOGAD-MS features at onset, but 5 of the latter group developed an MS-like course during follow-up. Five of 7 patients with assessable samples were Epstein-Barr virus seropositive at disease onset, and all 8 had persistent silent radiologic activity with lesional location and morphology suggestive of MS, leading to initiation of DMT. All initial treatments were well tolerated, but eventually, 7 of 8 children (88%) required high-efficacy DMT.DiscussionIn this pediatric cohort, 4% of patients with MOG-IgG met criteria for MS. The clinical-radiologic spectrum ranged from typical MS to overlapping MOGAD-MS, and patients usually required high-efficacy DMT.
Repisalud
Publicación Artículo científico (JournalArticle)

The mutation of Transportin 3 gene that causes limb girdle muscular dystrophy 1F induces protection against HIV-1 infection

  • Rodriguez‑Mora, Sara
  • De Wit, Flore
  • García-Pérez, Javier
  • Bermejo, Mercedes
  • Lopez-Huertas, Maria Rosa
  • Mateos, Elena
  • Marti, Pilar
  • Rocha, Susana
  • Vigon-Hernandez, Lorena
  • Christ, Frauke
  • Debyser, Zeger
  • Vílchez, Juan Jesús
  • Coiras, Mayte
  • Alcamí, José
The causative mutation responsible for limb girdle muscular dystrophy 1F (LGMD1F) is one heterozygous single nucleotide deletion in the stop codon of the nuclear import factor Transportin 3 gene (TNPO3). This mutation causes a carboxy-terminal extension of 15 amino acids, producing a protein of unknown function (TNPO3_mut) that is co-expressed with wild-type TNPO3 (TNPO3_wt). TNPO3 has been involved in the nuclear transport of serine/arginine-rich proteins such as splicing factors and also in HIV-1 infection through interaction with the viral integrase and capsid. We analyzed the effect of TNPO3_mut on HIV-1 infection using PBMCs from patients with LGMD1F infected ex vivo. HIV-1 infection was drastically impaired in these cells and viral integration was reduced 16-fold. No significant effects on viral reverse transcription and episomal 2-LTR circles were observed suggesting that the integration of HIV-1 genome was restricted. This is the second genetic defect described after CCR5Δ32 that shows strong resistance against HIV-1 infection.
IRTA Pubpro. Open Digital Archive
Publicación Artículo científico (JournalArticle)

Structural and functional divergence of two fish aquaporin-1 water channels following teleost-specific gene duplication

  • Sequeira, Angela
  • Chauvigné, François
  • Fabra, Mercedes
  • Lozano, Juanjo
  • Raldua, Demetrio
  • Cerdà Luque, Joan
Background: Teleost radiation in the oceans required specific physiological adaptations in eggs and early embryos to survive in the hyper-osmotic seawater. Investigating the evolution of aquaporins (AQPs) in these vertebrates should help to elucidate how mechanisms for water homeostasis evolved. The marine teleost gilthead sea bream (Sparus aurata) has a mammalian aquaporin-1 (AQP1)-related channel, termed AQP1o, with a specialized physiological role in mediating egg hydration. However, teleosts have an additional AQP isoform structurally more similar to AQP1, though its relationship with AQP1o is unclear. Results: By using phylogenetic and genomic analyses we show here that teleosts, unlike tetrapods, have two closely linked AQP1 paralogous genes, termed aqp1a and aqp1b (formerly AQP1o). In marine teleosts that produce hydrated eggs, aqp1b is highly expressed in the ovary, whereas in freshwater species that produce non-hydrated eggs, aqp1b has a completely different expression pattern or is not found in the genome. Both Aqp1a and Aqp1b are functional water-selective channels when expressed in Xenopus laevis oocytes. However, expression of chimeric and mutated proteins in oocytes revealed that the sea bream Aqp1b C-terminus, unlike that of Aqp1a, contains specific residues involved in the control of Aqp1b intracellular trafficking through phosphorylationindependent and -dependent mechanisms. Conclusion: We propose that 1) Aqp1a and Aqp1b are encoded by distinct genes that probably originated specifically in the teleost lineage by duplication of a common ancestor soon after divergence from tetrapods, 2) Aqp1b possibly represents a neofunctionalized AQP adapted to oocytes of marine and catadromous teleosts, thereby contributing to a water reservoir in eggs and early embryos that increases their survival in the ocean, and 3) Aqp1b independently acquired regulatory domains in the cytoplasmatic C-terminal tail for the specific control of Aqp1b expression in the plasma membrane., This work was supported by grants from the Spanish Ministry of Education and Science (MEC, Spain; AGL2004-00316 and AGL2007-60262) and the European Commission (Q5RS-2002-00784-CRYOCYTE) to JC. Participations of FC, MF and DR were supported by the European Commission (Marie Curie Research Training Network Aqua(glycero)porins, MRTN-CT- 2006-035995), a predoctoral scholarship from the Departament d'Universitats, Recerca i Societat de la Informació (Catalan Government, Spain), and by a Ramón y Cajal contract (MEC, Spain)., info:eu-repo/semantics/publishedVersion
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Three-Component Copper-Phosphonate-Auxiliary Ligand Systems: Proton Conductors and Efficient Catalysts in Mild Oxidative Functionalization of Cycloalkanes

  • Armakola, Eirini
  • Colodrero, Rosario M. P.
  • Bazaga-García, Montse
  • Salcedo, I. R.
  • Choquesillo-Lazarte, Duane
  • Cabeza, A.
  • Kirillova, M. V.
  • Kirillov, Alexander M.
  • Demadis, Konstantinos D.
The synthesis, structural characterization, topological analysis, proton conductivity, and catalytic properties are reported of two Cu(II)-based compounds, namely a dinuclear Cu(II) complex [Cu(μ-VPA)(phen)(HO)]·8HO (1) (HVPA = vinylphosphonic acid, phen = 1,10-phenanthroline) and a 1D coordination polymer [Cu(μ-SO)(phen)(HO)] (2). Their structural features and H-bonding interactions were investigated in detail, showing that the metal-organic structures of 1 and 2 are extended by multiple hydrogen bonds to more complex 2D or 1D H-bonded architectures with the kgd [Shubnikov plane net (3.6.3.6)/dual] and SP 1-periodic net (4,4)(0,2) topology, respectively. These nets are primarily driven by the H-bonding interactions involving water ligands and HO molecules of crystallization; besides, the (HO)/(HO) clusters were identified in 1. Both 1 and 2 are moderate proton conductors, with proton conductivity values, σ = 3.65 × 10 and 3.94 × 10 S·cm, respectively (measured at 80 °C and 95% relative humidity). Compounds 1 and 2 are also efficient homogeneous catalysts for the mild oxidative functionalization of C-C cycloalkanes (cyclopentane, cyclohexane, cycloheptane, and cyclooctane), namely for the oxidation by HO to give cyclic alcohols and ketones and the hydrocarboxylation by CO/HO and SO to the corresponding cycloalkanecarboxylic acids as major products. The catalytic reactions proceed under mild conditions (50-60 °C) in aqueous acetonitrile medium, resulting in up to 34% product yields based on cycloalkane substrate., Financial support was given by the European LIFE Project ADAPTAMED (LIFE14 CCA/ES/000612), (CGL2016‐80687‐R AEI/FEDER) DAMAGE, Spanish MINECO (grant JC2015‐00316 and project CGL2014‐61610‐EXP), and ERDF. The work was also partially developed as part of project ECOPOTENTIAL, which received funding from the European Union's Horizon 2020 Research and Innovation Program under grant agreement 641762.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Monocytes from inflammatory arthritis patients accumulate methotrexate and their transcriptome predicts methotrexate clinical response

  • Ríos, Israel
  • Schiaffino, María Teresa
  • López-Navarro, Baltasar
  • Triguero-Martínez, Ana
  • Lin, Marry
  • Torres-Torresano, Mónica
  • Struys, Eduard A.
  • Álvarez, Susana
  • Román, Manuel
  • Abad-Santos, Francisco
  • Castañeda, Santos
  • Garcia-Castañeda, Noelia
  • de Jonge, Robert
  • Jansen, Gerrit
  • Castrejón, Isabel
  • González-Álvaro, Isidoro
  • Puig-Kröger, Amaya
Monocytes and monocyte-derived macrophages play a key pathogenic role in inflammatory arthritis. Methotrexate (MTX) is the first-line disease-modifying antirheumatic drug (DMARD) for arthritis, yet the mechanisms and kinetics of its effects on monocyte/macrophages remain poorly understood. We have now investigated the temporal dynamics of the MTX's anti-inflammatory action by initially performing a phase I clinical trial (METOMAC) on healthy individuals following a single MTX dose, which revealed that MTX plasma levels peak at 1 h after MTX treatment, with maximal suppression of LPS-induced IL-1β and IL-6 in whole blood 5 days after MTX exposure. Building on these findings, we performed an observational clinical study (METOMAC-PAC) on 29 DMARD-naïve early arthritis patients receiving a weekly dose of MTX over a 3 month period. The METOMAC-PAC study revealed that MTX polyglutamates (MTX-PG) accumulates in peripheral blood monocytes, where MTX-PG is detected as early as 5 days post-treatment, and modulates the monocyte gene profile after 4 MTX doses, with specific enrichment of the aryl-hydrocarbon receptor (AhR)-molecular signature and genes coding for anti-inflammatory factors. Importantly, stratification of METOMAC-PAC patients according to their clinical response revealed that Good Responders exhibit increased expression of “non-classical monocyte”-specific genes (MAF, FCGR3B, ICAM4) both before and after MTX treatment, while Partial Responders patients showed a higher baseline expression of genes preferentially expressed by “classical monocytes”. Our results elucidate the kinetics of the anti-inflammatory action of MTX, demonstrate that MTX modulates the monocyte transcriptional signature in vivo, and identify “non-classical monocyte”-associated genes as predictors for an effective MTX clinical response, This work was supported by Grants PI20/00316 and PI23/00224 to APK, PI20/00847 and PI23/01226 to IC, RETIC RIER RD16/0012/0011 to IGA, Red de Enfermedades Inflamato rias (REI, RICORS RD21/0002/0034 and RD24/0007/0029 to APK; RD21/0002/0027 and RD24/0007/0006 to IGA), from Instituto de Salud Carlos III and cofinanced by the European Regional Develop ment Fund “A way to achieve Europe” (ERDF), and Dirección Gen eral de Innovación e Investigación Tecnológica de la Comunidad de Madrid (RETAR-A-COVID P2022/BMD-7274) to APK. IR was fund ed by a Formación de Personal Investigador predoctoral fellowship from Ministerio de Ciencia e Innovación (Grant PRE2021-097080, PID2020-114323RB-I00 from Ministerio de Ciencia e Innovación). ATM was funded by a Sara Borrell postdoctoral contract (CD25/00010 from Instituto de Salud Carlos III). RdJ received grants from the NVKC (Dutch Society for Clinical Chemistry)., Peer reviewed, in vitro - Tipos celulares - líneas celulares primarias
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma

  • González-Martínez, Silvia
  • Pérez-Mies, Belén
  • Palacios-Berraquero, María Luisa
  • Perez-Garcia, Jose Manuel
  • Cortés Castan, Javier
  • Carretero-Barrio, Irene
Carcinoma de mama metaplàsic; Alteracions moleculars; Pronòstic, Carcinoma de mama metaplásico; Alteraciones moleculares; Pronóstico, Metaplastic breast carcinoma; Molecular alterations; Prognosis, Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent invasive carcinomas that display differentiation of the neoplastic epithelium towards squamous cells and/or mesenchymal-type elements. Most MBC have a triple negative phenotype and poor prognosis. Thus, MBC have worse survival rates than other invasive breast carcinomas, including other triple negative breast carcinomas (TNBC). In this study, we reviewed the molecular features of MBC, pointing out the differences among subtypes. The most frequently mutated genes in MBC were TP53 and PIK3CA. Additionally, mutations in the other genes of the PI3K/AKT pathway indicated its importance in the pathogenesis of MBC. Regarding copy number variations (CNVs), MYC was the most frequently amplified gene, and the most frequent gene loss affected the CDKN2A/CDKN2B locus. Furthermore, the pattern of mutations and CNVs of MBC differed from those reported in other TNBC. However, the molecular profile of MBC was not homogeneous among histological subtypes, being the alterations in the PI3K pathway most frequent in spindle cell carcinomas. Transcriptomic studies have demonstrated an epithelial to mesenchymal program activation and the enrichment of stemness genes in most MBC. In addition, current studies are attempting to define the immune microenvironment of these tumors. In conclusion, due to specific molecular features, MBC have a different clinical behavior from other types of TNBC, being more resistant to standard chemotherapy. For this reason, new therapeutic approaches based on tumor molecular characteristics are needed to treat MBC., This review was funded by grants from the Instituto de Salud Carlos III (ISCIII) (PI19/01331) and CIBERONC (CB16/12/00316 and CB16/12/00449), co-financed by the European Development Regional Fund. ‘A way to achieve Europe’ (FEDER), and by the Spanish Association Against Cancer Scientific Foundation (Grupos Coordinados Traslacionales aecc 2018).
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Structural and functional divergence of two fish aquaporin-1 water channels following teleost-specific gene duplication

  • Sequeira, Angela
  • Chauvigné, François
  • Fabra, Mercedes
  • Lozano, Juanjo
  • Raldua, Demetrio
  • Cerdà Luque, Joan
Background: Teleost radiation in the oceans required specific physiological adaptations in eggs and early embryos to survive in the hyper-osmotic seawater. Investigating the evolution of aquaporins (AQPs) in these vertebrates should help to elucidate how mechanisms for water homeostasis evolved. The marine teleost gilthead sea bream (Sparus aurata) has a mammalian aquaporin-1 (AQP1)-related channel, termed AQP1o, with a specialized physiological role in mediating egg hydration. However, teleosts have an additional AQP isoform structurally more similar to AQP1, though its relationship with AQP1o is unclear. Results: By using phylogenetic and genomic analyses we show here that teleosts, unlike tetrapods, have two closely linked AQP1 paralogous genes, termed aqp1a and aqp1b (formerly AQP1o). In marine teleosts that produce hydrated eggs, aqp1b is highly expressed in the ovary, whereas in freshwater species that produce non-hydrated eggs, aqp1b has a completely different expression pattern or is not found in the genome. Both Aqp1a and Aqp1b are functional water-selective channels when expressed in Xenopus laevis oocytes. However, expression of chimeric and mutated proteins in oocytes revealed that the sea bream Aqp1b C-terminus, unlike that of Aqp1a, contains specific residues involved in the control of Aqp1b intracellular trafficking through phosphorylationindependent and -dependent mechanisms. Conclusion: We propose that 1) Aqp1a and Aqp1b are encoded by distinct genes that probably originated specifically in the teleost lineage by duplication of a common ancestor soon after divergence from tetrapods, 2) Aqp1b possibly represents a neofunctionalized AQP adapted to oocytes of marine and catadromous teleosts, thereby contributing to a water reservoir in eggs and early embryos that increases their survival in the ocean, and 3) Aqp1b independently acquired regulatory domains in the cytoplasmatic C-terminal tail for the specific control of Aqp1b expression in the plasma membrane., This work was supported by grants from the Spanish Ministry of Education and Science (MEC, Spain; AGL2004-00316 and AGL2007-60262) and the European Commission (Q5RS-2002-00784-CRYOCYTE) to JC. Participations of FC, MF and DR were supported by the European Commission (Marie Curie Research Training Network Aqua(glycero)porins, MRTN-CT- 2006-035995), a predoctoral scholarship from the Departament d'Universitats, Recerca i Societat de la Informació (Catalan Government, Spain), and by a Ramón y Cajal contract (MEC, Spain)., info:eu-repo/semantics/publishedVersion
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Charcot-Marie-Tooth disease due to MORC2 mutations in Spain

  • Sivera, Rafael|||0000-0003-2810-1180
  • Lupo, Vincenzo|||0000-0002-3774-9854
  • Frasquet, Marina
  • Argente-Escrig, Herminia
  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Querol, Luis|||0000-0002-4289-8264
  • García-Romero, María del Mar
  • Ignacio Pascual, Samuel
  • García-Sobrino, Tania|||0000-0001-8067-431X
  • Paradas, Carmen|||0000-0002-6917-2236
  • Vázquez-Costa, Juan F.|||0000-0002-3043-7938
  • Muelas, Nuria|||0000-0002-2349-7481
  • Millet, Elvira
  • Vílchez, Juan J.|||0000-0002-0532-2872
  • Espinós, Carmen|||0000-0003-4435-1809
  • Sevilla, T.
IIB., Background and purpose: MORC2 mutations have been described as a rare cause of axonal Charcot-Marie-Tooth disease (CMT2Z). The aim of this work was to determine the frequency and distribution of these mutations throughout Spain, to provide a comprehensive phenotypical description and, if possible, to establish a genotype-phenotype correlation. Methods: Retrospectively, data on patients diagnosed with CMT2Z in Spain were collected and clinical, electrophysiological and muscle imaging information were analysed. Results: Fifteen patients with CMT2Z were identified throughout Spain, seven of them belonging to a single kindred, whilst the rest were sporadic. The most common mutation was p.R252W, and four new mutations were identified. Eleven patients were categorized as having a scapuloperoneal phenotype, with asymmetric muscle weakness, early proximal upper limb involvement and frequent spontaneous muscular activity with distal sensory impairment and pes cavus, whilst two presented with a more classic length dependent sensory motor phenotype. This distinction was corroborated by the distribution of muscle fatty infiltration in muscle imaging. Two other patients were classified as having a neurodevelopmental phenotype consisting in congenital or early onset, delay in motor milestones, and global developmental delay in one of them. Nerve conduction studies revealed an unequivocally axonal neuropathy with frequent spontaneous activity, and serum creatine kinase levels were increased in 50% of the patients. Conclusions: MORC2 mutations are a rare cause of CMT in Spain, but in-depth phenotyping reveals a recognizable phenotypic spectrum that will be clinically relevant for future identification of this disease.
Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Dystrophinopathy Phenotypes and Modifying Factors in Exon 45-55 Deletion

  • Poyatos-García, Javier|||0000-0003-3117-4743
  • Martí, Pilar|||0000-0002-1022-9314
  • Liquori, Alessandro|||0000-0002-4842-5986
  • Muelas, Nuria|||0000-0002-2349-7481
  • Pitarch, Inmaculada|||0000-0002-3864-7374
  • Martinez-Dolz, Luis|||0000-0001-5145-8191
  • Rodríguez, Benjamin
  • González Quereda, Lidia|||0000-0003-0715-6414
  • Damiá, Maria|||0000-0003-2933-8438
  • Aller, Elena|||0000-0001-7973-5250
  • Selva-Gimenez, Marta|||0000-0003-4084-7356
  • Vilchez, Roger
  • Diaz-Manera, Jordi|||0000-0003-2941-7988
  • Alonso Pérez, Jorge|||0000-0001-8866-5186
  • Bárcena LLona, Jose Eulalio|||0000-0002-7156-5960
  • Jauregui, Amaia
  • Gamez, Josep|||0000-0003-3127-7486
  • Aladrén, Jesus Angel
  • Fernández, Ariadna
  • Montolio, Marisol|||0000-0001-5494-5737
  • Azorin, Inmaculada
  • Hervas, David|||0000-0003-0635-4961
  • Casasús, Ana
  • Nieto, Marisa
  • Gallano, Pia|||0000-0001-8104-2197
  • Sevilla, Teresa|||0000-0003-4716-2667
  • Vílchez, Juan J.|||0000-0002-0532-2872
Duchenne muscular dystrophy (DMD) exon 45-55 deletion (del45-55) has been postulated as a model that could treat up to 60% of DMD patients, but the associated clinical variability and complications require clarification. We aimed to understand the phenotypes and potential modifying factors of this dystrophinopathy subset. This cross-sectional, multicenter cohort study applied clinical and functional evaluation. Next generation sequencing was employed to identify intronic breakpoints and their impact on the Dp140 promotor, intronic long noncoding RNA, and regulatory splicing sequences. DMD modifiers (SPP1, LTBP4, ACTN3) and concomitant mutations were also assessed. Haplotypes were built using DMD single nucleotide polymorphisms. Dystrophin expression was evaluated via immunostaining, Western blotting, reverse transcription polymerase chain reaction (PCR), and droplet digital PCR in 9 muscle biopsies. The series comprised 57 subjects (23 index) expressing Becker phenotype (28%), isolated cardiopathy (19%), and asymptomatic features (53%). Cognitive impairment occurred in 90% of children. Patients were classified according to 10 distinct index-case breakpoints; 4 of them were recurrent due to founder events. A specific breakpoint (D5) was associated with severity, but no significant effect was appreciated due to the changes in intronic sequences. All biopsies showed dystrophin expression of.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publicación Artículo científico (JournalArticle)

Molecular Features of Metaplastic Breast Carcinoma: An Infrequent Subtype of Triple Negative Breast Carcinoma

  • González-Martínez, Silvia
  • Pérez-Mies, Belén
  • Palacios-Berraquero, María Luisa
  • Perez-Garcia, Jose Manuel
  • Cortés Castan, Javier
  • Carretero-Barrio, Irene
Carcinoma de mama metaplàsic; Alteracions moleculars; Pronòstic, Carcinoma de mama metaplásico; Alteraciones moleculares; Pronóstico, Metaplastic breast carcinoma; Molecular alterations; Prognosis, Metaplastic breast carcinoma (MBC) is a heterogeneous group of infrequent invasive carcinomas that display differentiation of the neoplastic epithelium towards squamous cells and/or mesenchymal-type elements. Most MBC have a triple negative phenotype and poor prognosis. Thus, MBC have worse survival rates than other invasive breast carcinomas, including other triple negative breast carcinomas (TNBC). In this study, we reviewed the molecular features of MBC, pointing out the differences among subtypes. The most frequently mutated genes in MBC were TP53 and PIK3CA. Additionally, mutations in the other genes of the PI3K/AKT pathway indicated its importance in the pathogenesis of MBC. Regarding copy number variations (CNVs), MYC was the most frequently amplified gene, and the most frequent gene loss affected the CDKN2A/CDKN2B locus. Furthermore, the pattern of mutations and CNVs of MBC differed from those reported in other TNBC. However, the molecular profile of MBC was not homogeneous among histological subtypes, being the alterations in the PI3K pathway most frequent in spindle cell carcinomas. Transcriptomic studies have demonstrated an epithelial to mesenchymal program activation and the enrichment of stemness genes in most MBC. In addition, current studies are attempting to define the immune microenvironment of these tumors. In conclusion, due to specific molecular features, MBC have a different clinical behavior from other types of TNBC, being more resistant to standard chemotherapy. For this reason, new therapeutic approaches based on tumor molecular characteristics are needed to treat MBC., This review was funded by grants from the Instituto de Salud Carlos III (ISCIII) (PI19/01331) and CIBERONC (CB16/12/00316 and CB16/12/00449), co-financed by the European Development Regional Fund. ‘A way to achieve Europe’ (FEDER), and by the Spanish Association Against Cancer Scientific Foundation (Grupos Coordinados Traslacionales aecc 2018).
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

The clonal relationship between the ductal and lobular components of mixed ductal-lobular carcinomas suggested a ductal origin in most tumors

  • Pérez Mies, Belén
  • Caniego Casas, Tamara
  • Carretero Barrio, Irene
  • Biscuola, Michele
  • López García, María A.
  • Hardisson Hernáez, David
  • Rosas, Marta
  • López Rodríguez, María J.
  • Cristóbal, Eva
  • Pizarro, David
  • Rosa Rosa, Juan Manuel
  • Palacios Calvo, José
The relationship between the ductal and lobular components of invasive ductolobular carcinomas (IDLC) has not been fully elucidated. In this study, the molecular alterations of both components were analyzed in a series of 20 IDLC that were selected, not only by morphologic criteria, but also by the loss of E-cadherin expression in the lobular component. We found that 80% of tumors shared alterations of driver genes in both components, being PIK3CA the most common alteration. In addition, 45% of IDLC carried CDH1 mutations in their lobular component that were absent in the ductal component. Fluorescent in situ hybridization analysis of the CDH1 gene excluded homozygous CDH1 loss as a frequent cause of E-cadherin loss in tumors without CDH1 mutations. In addition, no pathogenic mutations of catenin genes were detected in this series of tumors. In 25% of tumors, actionable mutations in PIK3CA , AKT1 , and ERBB2 were found in only 1 component. Altogether, our results confirm that most IDLC derive from invasive carcinoma of no special type, in which a population of cells lose E-cadherin and acquire a lobular phenotype. The frequency of CDH1 mutations in IDLC appears to be lower than in conventional invasive lobular carcinomas, suggesting the implication of alternative mechanisms of E-cadherin loss. Moreover, molecular heterogeneity between ductal and lobular areas suggests the need for molecular characterization of both components to guide targeted therapies., Instituto de Salud Carlos III, Ministerio de Economía y Competitividad, Fondo Europeo de Desarrollo Regional (FEDER)
e_Buah Biblioteca Digital Universidad de Alcalá
Publicación Artículo científico (JournalArticle)

High frequency of ERBB2 activating mutations in invasive lobular breast carcinoma with pleomorphic features

  • Rosa Rosa, Juan Manuel
  • Caniego Casas, Tamara
  • Leskela, Susanna
  • Cristóbal Lana, Eva María
  • González Martínez, Silvia
  • Moreno Moreno, Esther
  • López Miranda, Elena
  • Holgado Martín, Esther
  • Pérez Mies, Belén
  • Garrido López, María Pilar|||0000-0002-5899-6125
  • Palacios Calvo, José
19 p., Background: Characterisation of molecular alterations of pleomorphic lobular carcinoma (PLC), an aggressive subtype of invasive lobular carcinoma (ILC), have not been yet completely accomplished. Methods: To investigate the molecular alterations of invasive lobular carcinoma with pleomorphic features, a total of 39 tumour samples (in situ and invasive lesions and lymph node metastases) from 27 patients with nuclear grade 3 invasive lobular carcinomas were subjected to morphological, immunohistochemical and massive parallel sequencing analyses. Results: Our observations indicated that invasive lobular carcinomas with pleomorphic features were morphologically and molecularly heterogeneous. All cases showed absence or aberrant expression of E-cadherin and abnormal expression of ?-catenin and p120. CDH1 (89%), PIK3CA (33%) and ERRB2 (26%) were the most common mutated genes. ERBB2 mutations preferentially affected the tyrosine-kinase activity domain, being the most frequent the targetable mutation p.L755S (57%). We also observed higher frequency of mutations in ARID1B, KMT2C, MAP3K1, TP53 and ARID1A in PLC than previously reported in classic ILC. Alterations related to progression from in situ to invasive carcinoma and/or to lymph node metastases included TP53 mutation, amplification of PIK3CA and CCND1 and loss of ARID1A expression. Conclusions: The high frequency of ERBB2 mutations observed suggests that ERBB2 mutation testing should be considered in all invasive lobular carcinomas with nuclear grade 3., Ministerio de Economía y Competitividad, Fundación Científica Asociación Española Contra el Cáncer, Fundació la Marató de TV3